Therapeutic Strategies of Biologics in Chronic Rhinosinusitis: Current Options and Future Targets
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tai, J. | - |
dc.contributor.author | Han, M. | - |
dc.contributor.author | Kim, T. | - |
dc.date.accessioned | 2022-06-12T02:40:31Z | - |
dc.date.available | 2022-06-12T02:40:31Z | - |
dc.date.created | 2022-06-10 | - |
dc.date.issued | 2022-05 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/142091 | - |
dc.description.abstract | Chronic rhinosinusitis is a chronic inflammatory disease of the upper airways, for which treatment options include medical or surgical therapy. However, there are limitations to conservative treatment strategies, such as the relapse of nasal polyps. In this review, we discuss the rising role of biomolecular mechanisms associated with various biologics that have been approved or are undergoing clinical trials to treat chronic rhinosinusitis. We also highlight the potential molecular therapeutic targets for managing and treating chronic rhinosinusitis. © 2022 by the authors. Licensee MDPI, Basel, Switzerland. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.title | Therapeutic Strategies of Biologics in Chronic Rhinosinusitis: Current Options and Future Targets | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, T. | - |
dc.identifier.doi | 10.3390/ijms23105523 | - |
dc.identifier.scopusid | 2-s2.0-85129934263 | - |
dc.identifier.wosid | 000803160500001 | - |
dc.identifier.bibliographicCitation | International Journal of Molecular Sciences, v.23, no.10 | - |
dc.relation.isPartOf | International Journal of Molecular Sciences | - |
dc.citation.title | International Journal of Molecular Sciences | - |
dc.citation.volume | 23 | - |
dc.citation.number | 10 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | REFRACTORY CHRONIC RHINOSINUSITIS | - |
dc.subject.keywordPlus | GAMMA-INDUCIBLE PROTEIN-10 | - |
dc.subject.keywordPlus | NASAL POLYPS | - |
dc.subject.keywordPlus | MEPOLIZUMAB | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | OMALIZUMAB | - |
dc.subject.keywordPlus | CXCL10 | - |
dc.subject.keywordPlus | INTERFERENCE | - |
dc.subject.keywordPlus | EOSINOPHILS | - |
dc.subject.keywordPlus | RESLIZUMAB | - |
dc.subject.keywordAuthor | biologics | - |
dc.subject.keywordAuthor | chronic rhinosinusitis | - |
dc.subject.keywordAuthor | immunity | - |
dc.subject.keywordAuthor | monoclonal antibody | - |
dc.subject.keywordAuthor | therapeutic strategy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.